Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403523
Max Phase: Preclinical
Molecular Formula: C14H12N4O4
Molecular Weight: 300.27
Molecule Type: Small molecule
Associated Items:
ID: ALA3403523
Max Phase: Preclinical
Molecular Formula: C14H12N4O4
Molecular Weight: 300.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(N)Nc1ccc(C(=O)Oc2cccc([N+](=O)[O-])c2)cc1
Standard InChI: InChI=1S/C14H12N4O4/c15-14(16)17-10-6-4-9(5-7-10)13(19)22-12-3-1-2-11(8-12)18(20)21/h1-8H,(H4,15,16,17)
Standard InChI Key: LIJHCOQWUYPXSK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 300.27 | Molecular Weight (Monoisotopic): 300.0859 | AlogP: 2.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 131.34 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.09 | CX LogP: 2.55 | CX LogD: 1.78 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.20 | Np Likeness Score: -1.16 |
1. Franco FM, Jones DE, Harris PK, Han Z, Wildman SA, Jarvis CM, Janetka JW.. (2015) Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets., 23 (10): [PMID:25882520] [10.1016/j.bmc.2015.03.072] |
Source(1):